Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

ClinicalTrials.gov ID: NCT00049803

Public ClinicalTrials.gov record NCT00049803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) With Placebo for the Treatment of Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The initial portion of the protocol involves discontinuing any medications for cataplexy that the patient may be taking. Subsequently, the patient is prescribed a dose of oral solution of study drug or placebo over a 10-11 week period. During the trial, narcolepsy symptoms will be evaluated. Participants are allowed to continue using stimulant medications at constant doses during the study. A total of 1 to 3 daytime visits in addition to 4 overnight visits to the sleep center will be required to complete the study.

Study identification

NCT ID
NCT00049803
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Orphan Medical
Industry
Enrollment
200 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2000 (Type not available)
Primary completion
Not listed
Completion
Apr 2004 (Type not available)
Last update posted
Jun 24, 2005

2000 – 2004

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
Sleep Disorders Center of Alabama, Inc. Birmingham Alabama 35213 —
Pacific Sleep Medicine Services La Jolla California 92037-1205 —
Stanford Sleep Disorders Clinic Stanford California 94305 —
St. Petersburg Sleep Disorders Center St. Petersburg Florida 33707 —
Sleep Disorders Center of Georgia Atlanta Georgia 30342 —
Sleep Disorders Center--Division of Neurology Evanston Illinois 60201 —
Peoria Pulmonary Associates, Ltd. Peoria Illinois 61603 —
The Center for Sleep and Wake Disorders/Midwest Neurology Danville Indiana 46122 —
Fort Wayne Neurological Center Fort Wayne Indiana 46804 —
Fort Wayne Neurological Center Fort Wayne Indiana 46805 —
Chest Medicine Associates DBA/Sleep Medicine Specialists Louisville Kentucky 40217 —
LSU Health Science Center Shreveport Louisiana 71130 —
Center for Sleep and Wake Disorders Chevy Chase Maryland 20815 —
Center for Sleep Diagnostics Newton Massachusetts 02459 —
Department of Neurology Worcester Massachusetts 01608 —
Washington University -- Sleep Medicine Center St Louis Missouri 63108 —
Sleep/Wake Center 7N2 -- Bellevue Hospital Center New York New York 10016 —
The Sleep Center - Community General Hospital Syracuse New York 13215 —
Duke University Medical Center Durham North Carolina 27710 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
Central Carolina Neurology & Sleep Salisbury North Carolina 28144 —
CSC Research -- Grove City Sleep Diagnostic Center Grove City Ohio 43123 —
Southwest Cleveland Sleep Center Middleburg Heights Ohio 44130 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Clinical Pharmaceutical Trials, Inc. Tulsa Oklahoma 74104 —
Rhode Island Hospital - Division of Pulmonary, Sleep and Critical Care Medicine Providence Rhode Island 02903 —
Miriam Hospital Providence Rhode Island 02906 —
Charleston Pulmonary Associates PA Charleston South Carolina 29403 —
Low Country Lung and Critical Care PA Charleston South Carolina 29406-7108 —
Palmetto Baptist Medical Center Sleep Disorders Center Columbia South Carolina 29201 —
Charleston Pulmonary Associates PA Mt. Pleasant South Carolina 29464 —
Sleep Medicine Assoc PLLC -- Summit Medical Center Hermitage Tennessee 37076 —
The Houston Sleep Center Houston Texas 77024 —
Sleep Medicine Associates of Texas Plano Texas 75093 —
Sleep Disorders Center -- Eastern Virginia Medical School -- Sentara General Hospital Norfolk Virginia 23507 —
VCU Health System MCV Hospitals - Sleep Disorders Center Richmond Virginia 23235 —
Swedish Sleep Medicine Institute Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00049803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00049803 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →